Core Viewpoint - The successful implementation of the EVO+ICL(V5) surgery at Shanghai Aier Eye Hospital marks a significant advancement in vision correction technology, particularly for individuals with high demands for night vision quality, offering a revolutionary "day and night high-definition" experience [1][8]. Group 1: Technology and Innovation - The EVO+ICL(V5) technology features an expanded optical zone design that effectively reduces night glare and halos, making it particularly suitable for individuals with high night vision requirements [2][4]. - The new ICL technology can correct a wide range of vision issues, accommodating myopia from 50 to 1400 degrees and astigmatism up to 600 degrees, while being reversible and not requiring corneal cutting [2][4]. - The EVO+ICL(V5) lens has an optical zone that expands to 7.6mm, significantly improving night vision by better covering the dark pupil [4]. Group 2: Material and Manufacturing - The lens is made from a unique Collamer material, which offers high biocompatibility, flexibility, effective UV blockage, and excellent long-term safety, ensuring a stable and lasting high-definition visual experience [5]. - The manufacturing process utilizes Swiss precision engineering, focusing on meticulous detail and continuous innovation to provide cutting-edge visual quality [6]. Group 3: Clinical Validation and Experience - The ICL technology has been validated through over 30 years of clinical practice, with more than 3 million lenses implanted globally across 75 countries, highlighting its reliability and acceptance among both doctors and patients [7]. - The successful surgery at Shanghai Aier Eye Hospital reflects the institution's strong technical capabilities, supported by a history of completing 550,000 ICL surgeries by 2025 and extensive experience in correcting high myopia and complex refractive errors [8][9]. Group 4: Future Directions - The hospital aims to continue introducing and applying globally leading technologies to meet the diverse and refined visual needs of urban residents, emphasizing a patient-centered approach in providing safe, precise, and clear vision correction solutions [9].

Core Viewpoint - The launch of the EVO ICL (V5) crystal implantation surgery in Gansu marks the introduction of a cutting-edge myopia correction technology, allowing local patients to access advanced treatment without traveling abroad [2][3]. Group 1: Technology and Innovation - The EVO ICL V5 crystal features a key advancement with an optical zone diameter increased from 5.8 mm to 6.1 mm, significantly enhancing night vision quality for patients, especially those with larger pupils, and reducing glare and halos [2]. - The V5 crystal improves the correction precision for moderate to low myopia to a range of 25 degrees, promoting personalized treatment options [2]. - The crystal has high biocompatibility and UV-blocking capabilities, having undergone over 30 years of clinical validation globally, making it a reliable surgical choice due to its non-cutting, safe, and reversible nature [2]. Group 2: Clinical Implementation and Recognition - The V5 technology's regular implementation in Lanzhou signifies its official approval by national authorities, allowing patients in Gansu and the northwest region to benefit from this advanced technology locally [3]. - A plaque ceremony was held to establish the "EVO ICL V5 Crystal Gansu Clinical Application Popularization Alliance," highlighting the collaboration between STAAR company and local hospitals, along with the certification of the first surgical expert in Gansu [3][5]. Group 3: Safety and Patient Experience - The V5 crystal maintains the safety foundation of its predecessor, with innovations primarily in optical design, supported by over 40 precise preoperative examinations to ensure safety and effectiveness [5]. - Different myopia correction techniques cater to various needs, with the EVO ICL (V5) particularly suited for patients with high myopia (over 600 degrees) and those requiring enhanced night vision, such as drivers [5]. - Patient testimonials shared during the event highlighted improvements in night vision and overall quality of life, resonating with the audience [5]. Group 4: Future Directions - The Lanzhou Eye Hospital plans to continue introducing global innovative technologies, ensuring a comprehensive range of surgical options and strict quality control to provide safer, more precise, and personalized visual quality enhancement solutions for patients in the northwest region [5].

Core Insights - Aier Eye Hospital in Wuxi has successfully hosted the "Global ICL Surgery Volume Ten Consecutive Championships Expert Meeting," showcasing its expertise in ICL (Implantable Collamer Lens) surgeries and attracting numerous eye care experts and patients [1][10] - Since 2015, Aier Eye Hospital has completed over 550,000 ICL surgeries, maintaining its position as the global leader in this field for ten consecutive years, reflecting both technological advantages and patient trust in the Aier brand [1][8] Group 1: Technology and Expertise - ICL surgery is highlighted for its unique advantages, including non-invasive nature, preservation of the eye's original structure, and reversibility, making it a safer option for patients with high myopia and other complex eye conditions [2][4] - The hospital has established a team of experienced experts who provide personalized surgical plans based on comprehensive pre-operative assessments, ensuring high-quality visual outcomes for patients [4][10] Group 2: Patient Experience and Community Engagement - Patient testimonials during the event emphasized the trust in the hospital's technology and team, with employees sharing their positive experiences as both medical professionals and patients [5][7] - The event also served as a platform for promoting eye health knowledge and community service, with Aier Eye Hospital committed to making advanced myopia correction techniques accessible to more citizens [10] Group 3: Recognition and Future Plans - Aier Eye Hospital received the "Global ICL Surgery Volume First Medical Institution (2015-2025)" certification from STAAR Surgical, acknowledging its leadership and contributions in the ICL field [8][10] - The hospital plans to continue advancing ICL technology alongside other surgical methods, aiming to provide more personalized and safer visual health services for diverse patient populations [10]